Frontier Biotechnologies (SHSE:688221) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Frontier Biotechnologies Change In Receivables?

Frontier Biotechnologies's change in receivables for the quarter that ended in Mar. 2025 was ¥0.0 Mil. It means Frontier Biotechnologies's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Frontier Biotechnologies's change in receivables for the fiscal year that ended in Dec. 2024 was ¥38.6 Mil. It means Frontier Biotechnologies's Accounts Receivable declined by ¥38.6 Mil from Dec. 2023 to Dec. 2024 .

Frontier Biotechnologies's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥38.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Frontier Biotechnologies's Days Sales Outstanding for the three months ended in Mar. 2025 was 122.87.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Frontier Biotechnologies's liquidation value for the three months ended in Mar. 2025 was ¥170.9 Mil.

Frontier Biotechnologies Change In Receivables Historical Data

The historical data trend for Frontier Biotechnologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontier Biotechnologies Change In Receivables Chart

Frontier Biotechnologies Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-27.68

5.73

-58.03

2.43

38.60

Frontier Biotechnologies Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Frontier Biotechnologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Frontier Biotechnologies (SHSE:688221) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Frontier Biotechnologies's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	38.144	/	28.328	*	91
=	122.87

2. In Ben Graham's calculation of liquidation value, Frontier Biotechnologies's accounts receivable are only considered to be worth 75% of book value:

Frontier Biotechnologies's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	746.097	-	626.531	+	0.75 * 38.144	+	0.5 * 45.396
=	170.9

Frontier Biotechnologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of Frontier Biotechnologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontier Biotechnologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 5 Gande Road, 7th Floor, Science Park, Jiangning District, Jiangsu Province, Nanjing, CHN, 211122

Website

http://www.frontierbiotech.com

Frontier Biotechnologies Inc is an innovative biomedical company. It is engaged in the production and sales of innovative drugs for major unmet clinical needs. The company focuses on the research and development of new drugs in the field of long-acting peptides and differentiated product development strategies for unmet clinical and patient needs.

Frontier Biotechnologies Headlines

No Headlines